Calyx and Invicro agree to combine to create a global leader in medical imaging and software solutions for the clinical research community

LONDON and BOSTON, March 7, 2024 /PRNewswire/ -- Calyx, a leading technology-enabled provider of Medical Imaging services and IRT/RTSM (Interactive Response Technology/Randomised Trial Supply Management) to drug developers, and Invicro, a next-generation quantitative imaging biomarker company and pre-eminent development partner to pharma sponsors, have agreed to combine their business. This complementary combination will create a new global leader in the provision of medical imaging solutions and development services to the clinical research community.

Continue Reading

Union to create a truly differentiated industry leader and provide broader imaging support in response to customer needs

Post this

Preview

来源: PRNewswire

Calyx CEO David Heron is excited to combine the two complementary businesses in terms of their scientific talent, service offerings, and international presence to create a new industry-leading provider of medical imaging solutions and development services that span the complete R&D lifecycle from discovery through research and development to post-marketing.

Preview

来源: PRNewswire

Preview

来源: PRNewswire

Preview

来源: PRNewswire

Preview

来源: PRNewswire

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。